Hide

FocusBar

Subscribe to Premium Member
Carl Icahn

Carl Icahn

Last Update: 2013-05-15

Number of Stocks: 19
Number of New Stocks: 4

Total Value: $16,957 Mil
Q/Q Turnover: 10%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:
Please Subscribe to see portfolio changes after 2013-03-31.

Plans start from as little as $299/year. 7-Day FREE TRIAL

Carl Icahn Sold :



TickerCompanyDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OSK Oshkosh Corporation 2012-12-31 Sold Out -2.1%$26.85 - $31.42
($29.1)
$ 37.7430%Sold Out0
CMC Commercial Metals Co... 2012-12-31 Sold Out -0.94%$13.16 - $15
($13.89)
$ 15.7113%Sold Out0
MMI Motorola Mobility Ho... 2012-06-30 Sold Out -10.4%$38.31 - $39.99
($38.99)
$ 39.982%Sold Out0
CMC Commercial Metals Co... 2012-06-30 Reduce-0.38%$11.55 - $15.24
($13.17)
$ 15.7119%Reduce -23.67%7,981,275
EP El Paso Corp 2012-03-31 Sold Out -16.5%$26.08 - $30.18
($26)
$ 28.7511%Sold Out0
MSI Motorola Solutn 2012-03-31 Sold Out -15.2%$44.94 - $51.76
($45.68)
$ 57.325%Sold Out0
CLX The Clorox Company 2011-12-31 Sold Out -7.17%$63.71 - $69.56
($65.91)
$ 86.131%Sold Out0
VGR Vector Group Ltd. 2011-12-31 Sold Out -2.28%$16.08 - $17.12
($16.74)
$ 16.06-4%Sold Out0
ANX Adventrx Pharmaceuti... 2011-09-30 Sold Out $0.87 - $3.91
($1.97)
$ 0.72-64%Sold Out0
BIIB Biogen Idec Inc 2011-09-30 Sold Out -15.14%$85.03 - $107.91
($97.45)
$ 233.07139%Sold Out0
LGF Lions Gate Entertain... 2011-09-30 Sold Out -3.58%$6.36 - $7.55
($6.98)
$ 26.55280%Sold Out0
REGN Regeneron Pharmaceut... 2011-09-30 Sold Out -1.76%$44.96 - $72.19
($58.66)
$ 262.42347%Sold Out0
CHK Chesapeake Energy Co... 2011-09-30 Sold Out -1.05%$26.04 - $34.39
($31.1)
$ 21.1-32%Sold Out0
CYBX Cyberonics Inc. 2011-09-30 Sold Out -0.98%$23.7 - $30
($27.34)
$ 48.1276%Sold Out0
MAT Mattel Inc. 2011-09-30 Sold Out -0.97%$22.94 - $28
($26.23)
$ 45.8775%Sold Out0
AMGN Amgen Inc. 2011-09-30 Sold Out -0.87%$48.27 - $57.92
($54.59)
$ 104.5392%Sold Out0
NRG Nrg Energy Inc. 2011-09-30 Sold Out -0.82%$20.35 - $25.41
($23.16)
$ 27.7720%Sold Out0
TTWO Taketwo Interactive ... 2011-09-30 Reduce-0.63%$10.8 - $15.58
($13.27)
$ 15.8820%Reduce -25.79%7,305,626
EXEL Exelixis Inc. 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 4.58-38%Sold Out0
SUG Southern Union Co. 2011-09-30 Sold Out -0.09%$38.9 - $44.41
($42.05)
$ 0.345-99%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Carl Icahn's Profile:

Carl Icahn is an activist investor. He takes minority stakes in public companies and typically pushes for change. He invests with three investment vehicles: the 7 billion hedge fund, Icahn Partners, American Real Estate Partners (AREP), a public traded private equity firm, and ICAHN MANAGEMENT LP, a $2 billion hedge fund. GuruFocus tracks the third portfolio, which covers all the stocks owned by Icahn Partners. Mr. Icahn has a personal wealth of $17 billion.

» More Profile & Performance

Carl Icahn's Current Portfolio:

Ticker Shares Value ($1000)
IEP97,764,2515,329,130
CVI71,198,7183,675,280
CHK59,698,6891,218,450
FRX30,662,0051,166,380
RIG20,154,0351,047,200
NFLX5,541,0661,049,530
HLF16,355,131612,500
ARII11,871,268554,863
FDML76,697,804462,488
HAIN7,239,963442,217
» More Current Portfolio

Carl Icahn's Sector Weightings:


SectorsSector Weightings (%)
Technology 37.1% 37.1%
Industrials 21.7% 21.7%
Energy 13.4% 13.4%
Consumer Cyclical 8.9% 8.9%
Healthcare 7% 7%
Consumer Defensive 6.2% 6.2%
Communication Services 0% 0%
» More Sector Weightings

Carl Icahn's News:

» More Related News


Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK